For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant ...

For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant medications prescribed and ...

Marty Makary, President Trump’s pick to be FDA commissioner, promised to step down as an adviser to various health tech, ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured ...

Chronic Disease Flexible Coverage Act has passed the House of Representatives and will now go to the Senate. The bipar ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...